MTOR and metabolic dysfunction-associated steatohepatitis: Further studies to determine which factor is closely related to the activation of mTOR pathway and examine the association between mTOR pathway and the fibrotic process of the liver are needed to confirm the specificity of mTOR pathway activation in liver tumors with NASH and metabolic syndrome.